Ventricular Fibrillation and Polymorphic Ventricular Tachycardia with Critical Coronary Artery Stenosis:

ICD Therapy and CABG for Sudden Death. Introduction: Previous studies have suggested that coronary artery bypass surgery is sufficient to prevent recurrence of sudden death in patients with critical coronary artery stenosis presenting with ventricular fibrillation or polymorphic ventricular tachycardia. We present our experience in patients with one or more episodes of sudden death associated with documented ventricular fibrillation or polymorphic ventricular tachycardia and severe operable coronary artery disease who underwent defibrillator implant at the time of bypass surgery. Methods and Results: Fifty-eight consecutive patients (age 63 ± 8 years) were included in this study. Eighteen of the 58 patients had no evidence of previous myocardial infarction. The mean ejection fraction was 37 ± 13%. All patients underwent electrophysiologic study before and after revascularization. At the time of first defibrillator discharge, each patient was reevaluated to exclude the presence of ischemia. The benefits of defibrillator implant were estimated comparing the projected survival based upon defibrillator discharge preceded by syncope or presyncope with survival curves generated including total death and sudden plus cardiac death. After a mean follow-up of 4.6 ± 2 years, 22 patients received appropriate shocks preceded by syncope or presyncope, and an additional 19 patients received asymptomatic shocks. At 4 years, survival free of total death was 71.2%, and the projected survival was 58.8% (P < 0.05). Multivariate analysis showed that ejection fraction lower than 30% and induction of arrhythmia with one or two extrastimuii (S2, S3) were independent predictors for defibrillator discharge. None of the remaining variables including age, gender, number of bypasses, history of myocardial infarction, and type of arrhythmias induced were predictive for death and occurrence of shocks. Conclusions: In patients with ventricular fibrillation and polymorphic ventricular tachycardia, bypass surgery does not protect from recurrence of life-threatening arrhythmias, and, as in our population, defibrillator implant may have significant impact on survival.     

Harmonic Power Doppler Contrast Echocardiography: Preliminary Experimental Results

This preliminary experimental study demonstrates the potential usefulness of harmonic power Doppler imaging in producing left ventricular myocardial opacification and demonstrating intra-myocardial coronary vessels during contrast echocardiography using Levovist, a saccharide-based contrast agent. The contrast effect was most dramatic when a vasodilator such as dipyridamole or nitroglycerin was used in conjunction with contrast injections of Levovist. No significant myocardial opacification was noted with B-mode harmonic imaging alone.     

Sensing Failure in a Tiered Therapy Implantable Cardioverter Defibrillator: Role of Auto Adjustable Gain

WASE A., et.al .: Sensing Failure in a Tiered Therapy Implantable Cardioverter Defibrillator: Role of Auto Adjustable Gain . Implantable cardioverter defibrillators have an established role in the management of life-threatening tachyarrhythmias. These devices use sophisticated sensing circuitry to detect and promptly treat a vast majority of these arrhythmias. However, they are not foolproof. We report one case where the device failed to sense every other QRS complex during induced ventricular fibrillation due to marked electrical alterans. Thus, undersensing can be a potentially fatal problem despite the use of auto adjustable gain.     

MUSCLE PAIN FOLLOWING ADMINISTRATION OF SUXAMETHONIUM TO PREGNANT AND NON-PREGNANT PATIENTS UNDERGOING LAPAROSCOPIC TUBAL LIGATION

The frequency of muscle pain following suxamethonium was studiedin 50 pregnant (8–13 weeks' gestation) and 100 non-pregnantwomen, undergoing laparoscopic tubal ligation. The incidenceof muscle pain in the non-pregnant group was 42%, but only 20%in the pregnant women. The intensity of fasciculation was lessin the pregnant patients. It appears that pregnancy protectsthe patient from suxamethonium pains, even during the firsttrimester.     

Arrhythmogenic Potential of Pulmonary Venous Tissue: Triggers for Atrial Fibrillation Identified within the Remnant of a Vein

Background: Pulmonary veins (PVs) have frequently been identified as triggers for atrial fibrillation (AF), and higher arrhythmogenic potential of superior PVs has been attributed to their larger size, which can more rigorously support abnormalities of impulse formation and/or conduction.
Case Report: Contrary to this belief, we report our observations in a 63-year-old patient with history of lung cancer, S/P left upper lobectomy, undergoing ablation for paroxysmal AF. Circular mapping (Lasso) and ablation (ABL; 8-mm) catheters were deployed in left atrium (LA). Intracardiac ultrasound revealed separate right superior (RS) and inferior (RI) PVs and a single left PV. Segmented LA anatomy from the CT angiogram images corroborated this, although on the latter there appeared to be a "stump" at superior aspect of the left PV. This stump likely was the remnant of the left superior (LS) PV. Thus, the patent left vein was likely the dilated left inferior (LI) PV. With the Lasso and ABL deployed at the LIPV ostium and LSPV remnant, respectively, AF was reproducibly seen to initiate with earliest activity in the latter. Single radio-frequency ablation (RFA) lesion within the LSPV remnant abolished AF triggers. Additional RFA was done to isolate LI, RS, and RI PVs. Over a follow-up period of 24 months, this patient has remained free from AF off any drugs.
Conclusions: Our observations suggest that even very proximal remnants of PVs can serve as triggers for AF. Recognition of this phenomenon was facilitated by the use of advanced imaging technique and the deployment of multiple catheters.